Booster Vaccination With GVGH

Adult Antibodies, Bacterial / blood Female Healthy Volunteers Humans Immunization, Secondary / adverse effects Immunoglobulin G / blood Immunologic Memory Lipopolysaccharides / immunology Male Middle Aged Shigella Vaccines / adverse effects Shigella sonnei / immunology Vaccination / adverse effects
1790GAHB GMMA (generalized modules for membrane antigen) Shigella sonnei antibody persistence booster response safety

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 04 01 2019
accepted: 08 02 2019
entrez: 26 3 2019
pubmed: 25 3 2019
medline: 18 9 2020
Statut: epublish

Résumé

The investigational

Identifiants

DOI: 10.3389/fimmu.2019.00335 PMID: 30906291 PMC: PMC6418009
pubmed: 30906291
doi: 10.3389/fimmu.2019.00335
pmc: PMC6418009
doi:

Substances chimiques

Antibodies, Bacterial 0
Immunoglobulin G 0
Lipopolysaccharides 0
Shigella Vaccines 0

Banques de données

ClinicalTrials.gov
['NCT03089879']

Types de publication

Clinical Trial, Phase I Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

335

Références

J Infect Dis. 1999 Jun;179(6):1565-8
pubmed: 10228084
Microbiol Rev. 1991 Jun;55(2):206-24
pubmed: 1886518
Am J Epidemiol. 1991 Sep 15;134(6):614-27
pubmed: 1951266
J Antimicrob Chemother. 2011 Nov;66(11):2527-35
pubmed: 21859815
Expert Rev Vaccines. 2013 Jan;12(1):43-55
pubmed: 23256738
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
J Clin Microbiol. 1989 Jan;27(1):162-7
pubmed: 2463995
Clin Infect Dis. 2014 Oct;59(7):933-41
pubmed: 24958238
Expert Rev Anti Infect Ther. 2015 Jan;13(1):69-80
pubmed: 25399653
Clin Microbiol Infect. 2015 Mar;21(3):252.e5-8
pubmed: 25658535
PLoS Negl Trop Dis. 2015 Jun 11;9(6):e0003708
pubmed: 26068698
PLoS One. 2015 Aug 06;10(8):e0134478
pubmed: 26248044
Vaccine. 2016 Jun 3;34(26):2887-2894
pubmed: 26979135
BMC Res Notes. 2016 Aug 30;9(1):422
pubmed: 27576729
EBioMedicine. 2017 Aug;22:164-172
pubmed: 28735965
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Lancet Glob Health. 2017 Dec;5(12):e1235-e1248
pubmed: 29132613
Vaccine. 2018 Jan 15;:null
pubmed: 29352598
Front Immunol. 2017 Dec 22;8:1884
pubmed: 29375556
Sci Rep. 2018 May 9;8(1):7389
pubmed: 29743642
J Infect Dis. 1988 May;157(5):1068-71
pubmed: 3283258
Infect Immun. 1996 Oct;64(10):4074-7
pubmed: 8926071
Lancet. 1997 Jan 18;349(9046):155-9
pubmed: 9111538
J Infect Dis. 1997 May;175(5):1128-33
pubmed: 9129076

Auteurs

Odile Launay (O)

Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Inserm CIC 1417, F-CRIN I-REIVAC, Paris, France.
Assistance Publique Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France.

Augustin G W Ndiaye (AGW)

GSK Vaccines Institute for Global Health, Siena, Italy.

Valentino Conti (V)

GSK Vaccines Institute for Global Health, Siena, Italy.

Pierre Loulergue (P)

Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Inserm CIC 1417, F-CRIN I-REIVAC, Paris, France.
Assistance Publique Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France.

Antonella Silvia Sciré (AS)

GSK Vaccines Institute for Global Health, Siena, Italy.

Anais Maugard Landre (AM)

Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Inserm CIC 1417, F-CRIN I-REIVAC, Paris, France.
Assistance Publique Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France.

Pietro Ferruzzi (P)

GSK Vaccines Institute for Global Health, Siena, Italy.

Naouel Nedjaai (N)

Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Inserm CIC 1417, F-CRIN I-REIVAC, Paris, France.
Assistance Publique Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France.

Lena Dorothee Schütte (LD)

GSK, Marburg, Germany.

Joachim Auerbach (J)

GSK Vaccines Institute for Global Health, Siena, Italy.

Elisa Marchetti (E)

GSK Vaccines Institute for Global Health, Siena, Italy.

Allan Saul (A)

GSK Vaccines Institute for Global Health, Siena, Italy.

Laura B Martin (LB)

GSK Vaccines Institute for Global Health, Siena, Italy.

Audino Podda (A)

GSK Vaccines Institute for Global Health, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Booster Vaccination With GVGH
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps antibactériens › Booster Vaccination With GVGH
questionsmedicales.fr › Personnes › Bénévoles › Volontaires sains › Booster Vaccination With GVGH
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Booster Vaccination With GVGH
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Rappel de vaccin › Booster Vaccination With GVGH
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Isotypes des immunoglobulines › Immunoglobuline G › Booster Vaccination With GVGH
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité acquise › Mémoire immunologique › Booster Vaccination With GVGH
questionsmedicales.fr › Facteurs biologiques › Toxines biologiques › Toxines bactériennes › Endotoxines › Lipopolysaccharides › Booster Vaccination With GVGH
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Booster Vaccination With GVGH
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antibactériens › Vaccins anti-shigella › Booster Vaccination With GVGH
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Shigella › Shigella sonnei › Booster Vaccination With GVGH
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › Booster Vaccination With GVGH